Sherwin Chen is listed as an executive officer on 2 SEC Form D filings by 2 issuers between Jan 2021 and Feb 2022: Color Health, Inc. (Burlingame, CA — biotechnology — 2021; $127.2M reported sold to 51 investors) and AllStripes Research Inc. (San Francisco, CA — other technology — 2022; $45.2M reported sold to 18 investors).
What this means 2 separate companies raised money with this person listed as executive officer. Across those companies the filings report $172.4M sold in total.
Listed alongside Adam Goulburn (1 shared filing), Andrew Firlik (1 shared filing), Gil Elad (1 shared filing), Hemant Taneja (1 shared filing), Nabeel Hyatt (1 shared filing) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Sherwin. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Sherwin Chen and found 5 differences, 1 worth asking the sponsor about: Form D filed 216 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.